ALKS vs CBOE · P/E 14, rev $1.56B vs P/E 24, $29.50B cap
Alkermes Plc (ALKS) versus Cboe Global Markets Inc (CBOE) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
CBOE does not have a complete income-statement cache yet.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Not investment advice. Open the ALKS and CBOE stock pages for the full models.
Not investment advice.